Stocks in play: Helix BioPharma Corp.
Has entered into a collaboration agreement with Moffitt Cancer Center to extract radiomics data using their proprietary HealthMyne platform from CT scans of late stage lung cancer patients treated with L-DOS47. Helix BioPharma Corp.